Life Technologies division Applied Biosystems said today that it plans to launch a new low-to-medium-throughput capillary electrophoresis sequencer this summer. A version of the instrument will comply with the European Union's in vitro diagnostic medical devices directive, the first of its CE systems to do so, the company said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.